80 FR 31602 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings With the Office of Orphan Products Development

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 106 (June 3, 2015)

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ``Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings with the Office of Orphan Products Development'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

[Federal Register Volume 80, Number 106 (Wednesday, June 3, 2015)]
[Notices]
[Page 31602]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-13472]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-0313]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Guidance for Industry, Researchers, 
Patient Groups, and FDA Staff on Meetings With the Office of Orphan 
Products Development

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled, ``Guidance for Industry, 
Researchers, Patient Groups, and FDA Staff on Meetings with the Office 
of Orphan Products Development'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, [email protected].

SUPPLEMENTARY INFORMATION: On March 4, 2015, the Agency submitted a 
proposed collection of information entitled, ``Guidance for Industry, 
Researchers, Patient Groups, and FDA Staff on Meetings with the Office 
of Orphan Products Development'' to OMB for review and clearance under 
44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is 
not required to respond to, a collection of information unless it 
displays a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0787. 
The approval expires on May 31, 2018. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.

    Dated: May 29, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-13472 Filed 6-2-15; 8:45 am]
BILLING CODE 4164-01-P